David Krempa | Chief Business Officer |
Sean Brynjelsen | CEO |
James Gruber | CFO |
Raghuram Selvaraju | H.C. Wainwright & Co |
Good afternoon and welcome to the Eton Pharmaceuticals' First Quarter 2023 Financial Results Conference Call. At this time, all participants are in a listen only mode.
Following the formal remarks, we will open the call up for your questions. Please be advised that this call is being recorded at the company's request.
At this time, I would like to turn it over to David Krempa, Chief Business Officer at Eton Pharmaceuticals.